Kevin J. Carroll

1.1k total citations
26 papers, 654 citations indexed

About

Kevin J. Carroll is a scholar working on Statistics and Probability, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Kevin J. Carroll has authored 26 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Statistics and Probability, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Economics and Econometrics. Recurrent topics in Kevin J. Carroll's work include Statistical Methods in Clinical Trials (13 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Statistical Methods and Inference (4 papers). Kevin J. Carroll is often cited by papers focused on Statistical Methods in Clinical Trials (13 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Statistical Methods and Inference (4 papers). Kevin J. Carroll collaborates with scholars based in United Kingdom, United States and Spain. Kevin J. Carroll's co-authors include Tom Morris, Tomasz Burzykowski, Don Newling, Fritz H. Schröder, Laurence Collette, Stuart H. Ellis, Kristine Pemberton, Thomas R. Fleming, Lucia Del Vecchio and Francesco Paolo Schena and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Gut.

In The Last Decade

Kevin J. Carroll

24 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin J. Carroll United Kingdom 12 210 161 127 88 87 26 654
Andrae Vandross United States 7 83 0.4× 91 0.6× 20 0.2× 103 1.2× 227 2.6× 19 547
Purna Mukhopadhyay United States 12 136 0.6× 20 0.1× 141 1.1× 116 1.3× 48 0.6× 27 679
Bill Poland United States 10 383 1.8× 52 0.3× 18 0.1× 245 2.8× 75 0.9× 14 677
Xiaojuan Li United States 16 53 0.3× 56 0.3× 19 0.1× 35 0.4× 94 1.1× 77 702
Anthony J. Hatswell United Kingdom 17 69 0.3× 108 0.7× 19 0.1× 204 2.3× 338 3.9× 65 826
Dal Ho Kim South Korea 10 98 0.5× 93 0.6× 44 0.3× 48 0.5× 54 0.6× 68 542
Stephen B. Ellis United States 13 40 0.2× 32 0.2× 66 0.5× 117 1.3× 33 0.4× 25 973
David T. Myers United States 6 62 0.3× 31 0.2× 69 0.5× 68 0.8× 34 0.4× 13 388
Francesca Tosato Italy 13 87 0.4× 82 0.5× 40 0.3× 30 0.3× 9 0.1× 36 608
Stefan Walzer Germany 16 233 1.1× 27 0.2× 15 0.1× 210 2.4× 232 2.7× 99 901

Countries citing papers authored by Kevin J. Carroll

Since Specialization
Citations

This map shows the geographic impact of Kevin J. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin J. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin J. Carroll more than expected).

Fields of papers citing papers by Kevin J. Carroll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin J. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin J. Carroll. The network helps show where Kevin J. Carroll may publish in the future.

Co-authorship network of co-authors of Kevin J. Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin J. Carroll. A scholar is included among the top collaborators of Kevin J. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin J. Carroll. Kevin J. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, John A., Surinder S. Birring, Michael S. Blaiss, et al.. (2025). Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE). American Journal of Respiratory and Critical Care Medicine. 211(6). 1038–1048. 4 indexed citations
2.
Sinha, Smeeta, Sagar U. Nigwekar, Vincent Brandenburg, et al.. (2024). Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension. EClinicalMedicine. 75. 102784–102784. 3 indexed citations
3.
4.
Getz, Elise Burmeister, Kevin J. Carroll, Johanna Mielke, Byron Jones, & Leslie Z. Benet. (2021). Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence Testing. AAPS PharmSciTech. 22(7). 224–224. 5 indexed citations
5.
Getz, Elise Burmeister, et al.. (2021). Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch Variability. AAPS PharmSciTech. 22(7). 225–225. 4 indexed citations
6.
Sinha, Smeeta, Lisa J. Gould, Sagar U. Nigwekar, et al.. (2021). The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clinical Kidney Journal. 15(1). 136–144. 19 indexed citations
7.
D’Costa, Matthew R., Annamaria T. Kausz, Kevin J. Carroll, et al.. (2020). Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria. Nephrology Dialysis Transplantation. 36(12). 2208–2215. 12 indexed citations
8.
Ouyang, John, Peter Zhang, Kevin J. Carroll, Jennifer Lee, & Gary G. Koch. (2019). Comparisons of global tests on intersection hypotheses and their application in matched parallel gatekeeping procedures. Journal of Biopharmaceutical Statistics. 30(4). 593–606. 1 indexed citations
9.
Brandenburg, Vincent, Smeeta Sinha, José‐Vicente Torregrosa, et al.. (2019). Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis. Journal of Nephrology. 32(5). 811–821. 28 indexed citations
10.
Benet, Leslie Z., et al.. (2019). Batch‐to‐Batch and Within‐Subject Variability: What Do We Know and How Do These Variabilities Affect Clinical Pharmacology and Bioequivalence?. Clinical Pharmacology & Therapeutics. 105(2). 326–328. 6 indexed citations
11.
Inker, Lesley A., Tom Greene, Francesco Locatelli, et al.. (2016). Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis. American Journal of Kidney Diseases. 68(3). 392–401. 94 indexed citations
12.
Carroll, Kevin J. & Florence Le Maulf. (2011). Japanese Guideline on Global Clinical Trials: Statistical Implications and Alternative Criteria for Assessing Consistency. Drug Information Journal. 45(5). 657–667. 4 indexed citations
13.
Nelson, Harold S., Catherine M. Bonuccelli, Finn Radner, et al.. (2010). Safety of formoterol in patients with asthma: Combined analysis of data from double-blind, randomized controlled trials. Journal of Allergy and Clinical Immunology. 125(2). 390–396.e8. 29 indexed citations
14.
Carroll, Kevin J.. (2009). Back to basics: explaining sample size in outcome trials, are statisticians doing a thorough job?. Pharmaceutical Statistics. 8(4). 333–345. 11 indexed citations
15.
Carroll, Kevin J.. (2007). Biomarkers in drug development: friend or foe? A personal reflection gained working within oncology. Pharmaceutical Statistics. 6(4). 253–260. 12 indexed citations
16.
Carroll, Kevin J.. (2007). Analysis of progression‐free survival in oncology trials: some common statistical issues. Pharmaceutical Statistics. 6(2). 99–113. 47 indexed citations
17.
Ellis, Stuart H., Kevin J. Carroll, & Kristine Pemberton. (2007). Analysis of duration of response in oncology trials. Contemporary Clinical Trials. 29(4). 456–465. 23 indexed citations
18.
19.
Carroll, Kevin J.. (2003). On the use and utility of the Weibull model in the analysis of survival data. Controlled Clinical Trials. 24(6). 682–701. 198 indexed citations
20.
Carroll, Kevin J., et al.. (1964). Superior mesenteric embolectomy. Gut. 5(4). 363–364. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrae Vandross Breakdown of academic impact, for papers by Purna Mukhopadhyay Breakdown of academic impact, for papers by Bill Poland Breakdown of academic impact, for papers by Xiaojuan Li Breakdown of academic impact, for papers by Anthony J. Hatswell Breakdown of academic impact, for papers by Dal Ho Kim Breakdown of academic impact, for papers by Stephen B. Ellis Breakdown of academic impact, for papers by David T. Myers Breakdown of academic impact, for papers by Francesca Tosato Breakdown of academic impact, for papers by Stefan Walzer
Rankless by CCL
2026